Vasu R. Sah

1.1k total citations
19 papers, 749 citations indexed

About

Vasu R. Sah is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Vasu R. Sah has authored 19 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Vasu R. Sah's work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers) and Ocular Oncology and Treatments (6 papers). Vasu R. Sah is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers) and Ocular Oncology and Treatments (6 papers). Vasu R. Sah collaborates with scholars based in Australia, United States and Sweden. Vasu R. Sah's co-authors include Krasimir Vasilev, Petr Martínek, Hans J. Griesser, Robert D. Short, Andrew Michelmore, Chi P. Ndi, Jonas A. Nilsson, Lars Ny, Henrik Jespersen and Joakim Karlsson and has published in prestigious journals such as Nature Communications, Nano Letters and Cancer Research.

In The Last Decade

Vasu R. Sah

19 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasu R. Sah Australia 10 224 212 180 179 168 19 749
Crystal S. Shin United States 13 368 1.6× 173 0.8× 115 0.6× 64 0.4× 15 0.1× 23 1.0k
Chenxi Ouyang China 13 187 0.8× 208 1.0× 66 0.4× 62 0.3× 44 0.3× 47 742
Nduka Enemchukwu United States 7 328 1.5× 181 0.9× 59 0.3× 41 0.2× 28 0.2× 8 677
Gloria B. Kim United States 12 374 1.7× 173 0.8× 106 0.6× 98 0.5× 122 0.7× 16 778
Seiichi Tada Japan 19 235 1.0× 483 2.3× 42 0.2× 85 0.5× 70 0.4× 56 965
Bong Geun South Korea 14 464 2.1× 271 1.3× 90 0.5× 378 2.1× 258 1.5× 21 1.1k
Rong Zhou China 20 145 0.6× 515 2.4× 333 1.9× 59 0.3× 190 1.1× 57 1.1k
Thanh-Huyen Tran United States 11 164 0.7× 391 1.8× 67 0.4× 76 0.4× 240 1.4× 12 808
Zhisheng Xiao China 18 661 3.0× 272 1.3× 113 0.6× 169 0.9× 237 1.4× 32 1.1k
Jae Chang Jung South Korea 10 204 0.9× 170 0.8× 38 0.2× 354 2.0× 23 0.1× 36 934

Countries citing papers authored by Vasu R. Sah

Since Specialization
Citations

This map shows the geographic impact of Vasu R. Sah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasu R. Sah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasu R. Sah more than expected).

Fields of papers citing papers by Vasu R. Sah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasu R. Sah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasu R. Sah. The network helps show where Vasu R. Sah may publish in the future.

Co-authorship network of co-authors of Vasu R. Sah

This figure shows the co-authorship network connecting the top 25 collaborators of Vasu R. Sah. A scholar is included among the top collaborators of Vasu R. Sah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasu R. Sah. Vasu R. Sah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Karlsson, Joakim, Vasu R. Sah, Roger Olofsson Bagge, et al.. (2024). Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases. eLife. 12. 2 indexed citations
2.
Karlsson, Joakim, Vasu R. Sah, Roger Olofsson Bagge, et al.. (2023). Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases. eLife. 12. 2 indexed citations
3.
Larsson, Peter, et al.. (2023). Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro. Frontiers in Cell and Developmental Biology. 11. 1237673–1237673. 6 indexed citations
4.
Sah, Vasu R., Henrik Jespersen, Joakim Karlsson, et al.. (2023). Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer Research Communications. 3(5). 884–895. 6 indexed citations
5.
Sah, Vasu R., Joakim Karlsson, Henrik Jespersen, et al.. (2021). Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma. Melanoma Research. 32(4). 241–248. 15 indexed citations
6.
Ny, Lars, Henrik Jespersen, Joakim Karlsson, et al.. (2021). The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma. Nature Communications. 12(1). 5155–5155. 120 indexed citations
7.
Karlsson, Joakim, Lisa M. Nilsson, Samuel Alsén, et al.. (2020). Molecular profiling of driver events in metastatic uveal melanoma. Nature Communications. 11(1). 1894–1894. 104 indexed citations
8.
Borodovsky, Alexandra, Yanjun Wang, Minwei Ye, et al.. (2018). Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models. Cancer Research. 78(13_Supplement). 3751–3751. 8 indexed citations
9.
Poon, Edmund, Stefanie Mullins, Amanda Watkins, et al.. (2017). The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment. Journal for ImmunoTherapy of Cancer. 5(1). 63–63. 59 indexed citations
10.
Woessner, Rich, Vasu R. Sah, Patricia McCoon, et al.. (2017). Abstract 3684: Inhibition of STAT3 by antisense oligonucleotide treatment decreases the immune suppressive tumor microenvironment in syngeneic and GEM tumor models. Cancer Research. 77(13_Supplement). 3684–3684. 1 indexed citations
11.
Borodovsky, Alexandra, Yanjun Wang, Minwei Ye, et al.. (2017). Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression. Cancer Research. 77(13_Supplement). 5580–5580. 19 indexed citations
12.
Asghar, Waseem, Hadi Shafiee, Vanessa Velasco, et al.. (2016). Toxicology Study of Single-walled Carbon Nanotubes and Reduced Graphene Oxide in Human Sperm. Scientific Reports. 6(1). 30270–30270. 46 indexed citations
13.
Woessner, Rich, Patricia McCoon, Kirsten Bell, et al.. (2015). Abstract A93: STAT3 inhibition enhances the activity of immune checkpoint inhibitors in murine syngeneic tumor models by creating a more immunogenic tumor microenvironment. Cancer Immunology Research. 3(10_Supplement). A93–A93. 2 indexed citations
14.
Woessner, Richard, Patricia McCoon, Shaun Grosskurth, et al.. (2015). Abstract A94: STAT3 antisense treatment decreases M2 macrophage infiltration and enhances the activity of checkpoint inhibitors in preclinical tumor models. Molecular Cancer Therapeutics. 14(12_Supplement_2). A94–A94. 2 indexed citations
15.
Sah, Vasu R. & Robert Baier. (2014). Bacteria Inside Semiconductors as Potential Sensor Elements: Biochip Progress. Sensors. 14(6). 11225–11244. 5 indexed citations
16.
Michelmore, Andrew, Petr Martínek, Vasu R. Sah, Robert D. Short, & Krasimir Vasilev. (2011). Surface Morphology in the Early Stages of Plasma Polymer Film Growth from Amine‐Containing Monomers. Plasma Processes and Polymers. 8(5). 367–372. 69 indexed citations
17.
Vasilev, Krasimir, Vasu R. Sah, Renee V. Goreham, et al.. (2010). Antibacterial surfaces by adsorptive binding of polyvinyl-sulphonate-stabilized silver nanoparticles. Nanotechnology. 21(21). 215102–215102. 71 indexed citations
18.
Vasilev, Krasimir, Andrew Michelmore, Petr Martínek, et al.. (2010). Early Stages of Growth of Plasma Polymer Coatings Deposited from Nitrogen‐ and Oxygen‐Containing Monomers. Plasma Processes and Polymers. 7(9-10). 824–835. 82 indexed citations
19.
Vasilev, Krasimir, Vasu R. Sah, Karine Anselme, et al.. (2009). Tunable Antibacterial Coatings That Support Mammalian Cell Growth. Nano Letters. 10(1). 202–207. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026